monoisoamyl-2,3-dimercaptosuccinate has been researched along with deoxyguanosine in 1 studies
| Studies (monoisoamyl-2,3-dimercaptosuccinate) | Trials (monoisoamyl-2,3-dimercaptosuccinate) | Recent Studies (post-2010) (monoisoamyl-2,3-dimercaptosuccinate) | Studies (deoxyguanosine) | Trials (deoxyguanosine) | Recent Studies (post-2010) (deoxyguanosine) |
|---|---|---|---|---|---|
| 53 | 0 | 19 | 6,470 | 225 | 2,167 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flora, SJS; Kushwaha, P; Samim, M; Yadav, A | 1 |
1 other study(ies) available for monoisoamyl-2,3-dimercaptosuccinate and deoxyguanosine
| Article | Year |
|---|---|
Combinatorial drug delivery strategy employing nano-curcumin and nano-MiADMSA for the treatment of arsenic intoxication in mouse.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Arsenic; Arsenic Poisoning; Curcumin; Deoxyguanosine; Drug Carriers; Drug Synergism; Enzymes; Glutathione; Liver; Male; Mice; Nanoparticles; Oxidative Stress; Reactive Oxygen Species; Succimer | 2018 |